Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph I Friedman

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Psychopharmacology|June 19, 2004
Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonistsJoseph I Friedman
The New England Journal of Medicine|July 21, 2021
Pimavanserin in Dementia-Related PsychosisJoseph I Friedman
Biological Psychiatry|September 26, 2006
Special issue: Molecular mechanisms of schizophreniaJoseph I Friedman, Kenneth L Davis
The Mount Sinai Journal of Medicine, New York|December 15, 2012
Novel imaging strategies for assessment of cerebrovascular involvementCheuk Ying Tang, Jagat Narula, Joseph I Friedman
CNS Spectrums|April 30, 2004
Potential noradrenergic targets for cognitive enhancement in schizophreniaJoseph I Friedman, Daniel G Stewart, Jack M Gorman
JACC. Cardiovascular Imaging|April 18, 2015
Reply: Asymptomatic cardiovascular risk assessment: the road less traveledJoseph I Friedman, Cheuk Y Tang, Zahi A Fayad, et al.
The Journal of Nervous and Mental Disease|December 8, 2004
Activation symptoms and discharge in elderly chronic schizophrenic inpatientsLeonard White, Lewis A Opler, Philip D Harvey, et al.
The American Journal of Psychiatry|December 24, 2013
Pharmacological treatments of non-substance-withdrawal delirium: a systematic review of prospective trialsJoseph I Friedman, Laili Soleimani, Daniel P McGonigle, et al.
Schizophrenia Research|November 29, 2007
Relationships between white matter metabolite abnormalities, cognitive and social functioning in elderly schizophrenic subjectsJoseph I Friedman, Kenneth L Davis, Linda Chang, et al.
Schizophrenia Research|May 17, 2005
Depressed mood and its functional correlates in institutionalized schizophrenia patientsNina Rieckmann, Abraham Reichenberg, Christopher R Bowie, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Psychopharmacology|June 19, 2004
Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonistsJoseph I Friedman
The New England Journal of Medicine|July 21, 2021
Pimavanserin in Dementia-Related PsychosisJoseph I Friedman
Biological Psychiatry|September 26, 2006
Special issue: Molecular mechanisms of schizophreniaJoseph I Friedman, Kenneth L Davis
The Mount Sinai Journal of Medicine, New York|December 15, 2012
Novel imaging strategies for assessment of cerebrovascular involvementCheuk Ying Tang, Jagat Narula, Joseph I Friedman
CNS Spectrums|April 30, 2004
Potential noradrenergic targets for cognitive enhancement in schizophreniaJoseph I Friedman, Daniel G Stewart, Jack M Gorman
JACC. Cardiovascular Imaging|April 18, 2015
Reply: Asymptomatic cardiovascular risk assessment: the road less traveledJoseph I Friedman, Cheuk Y Tang, Zahi A Fayad, et al.
The Journal of Nervous and Mental Disease|December 8, 2004
Activation symptoms and discharge in elderly chronic schizophrenic inpatientsLeonard White, Lewis A Opler, Philip D Harvey, et al.
The American Journal of Psychiatry|December 24, 2013
Pharmacological treatments of non-substance-withdrawal delirium: a systematic review of prospective trialsJoseph I Friedman, Laili Soleimani, Daniel P McGonigle, et al.
Schizophrenia Research|November 29, 2007
Relationships between white matter metabolite abnormalities, cognitive and social functioning in elderly schizophrenic subjectsJoseph I Friedman, Kenneth L Davis, Linda Chang, et al.
Schizophrenia Research|May 17, 2005
Depressed mood and its functional correlates in institutionalized schizophrenia patientsNina Rieckmann, Abraham Reichenberg, Christopher R Bowie, et al.
Pageof 4